quinuclidines has been researched along with Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, Y; Li, Y; Liu, Z; Yu, J; Yu, L | 1 |
| Brealey, N; Hardes, K; Kelleher, D; Mehta, R; Preece, A; Tombs, L | 1 |
1 trial(s) available for quinuclidines and Kidney Diseases
| Article | Year |
|---|---|
Effect of severe renal impairment on umeclidinium and umeclidinium/vilanterol pharmacokinetics and safety: a single-blind, nonrandomized study.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adult; Aged; Area Under Curve; Benzyl Alcohols; Bronchodilator Agents; Chlorobenzenes; Czech Republic; Drug Combinations; Dry Powder Inhalers; Female; Humans; Hungary; Kidney Diseases; Male; Middle Aged; Muscarinic Antagonists; Quinuclidines; Renal Elimination; Severity of Illness Index; Single-Blind Method | 2015 |
1 other study(ies) available for quinuclidines and Kidney Diseases
| Article | Year |
|---|---|
Penehyclidine hydrochloride inhibits renal ischemia/reperfusion-induced acute lung injury by activating the Nrf2 pathway.
Topics: Acute Lung Injury; Animals; Apoptosis; Disease Models, Animal; Gene Knockout Techniques; Humans; Kidney; Kidney Diseases; Lung; Macrophages, Alveolar; Male; NF-E2-Related Factor 2; Oxidative Stress; Quassins; Quinuclidines; Rats; Rats, Transgenic; Reactive Oxygen Species; Reperfusion Injury; Signal Transduction; tert-Butylhydroperoxide | 2020 |